Neurofibromatosis type 1 and Ras-mediated signaling: filling in the GAPs.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 7626654)

Published in Biochim Biophys Acta on July 28, 1995

Authors

A Bernards1

Author Affiliations

1: Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown 02129, USA.

Associated clinical trials:

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas | NCT00021541